Skip to content
thispeptide

Maves

Maves identifies Keeva Medical Group as its clinical partner for compounded treatments. Its individual products and bundles differ, while the older billing agreement still needs clarification.

Review by Leah Garner, clinical-evidence editor · Updated October 2026

The short version

The current consent clearly identifies the clinical group. Confirm the assigned professional and applicable billing terms before choosing a combined protocol.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Lowest listed: Sermorelin injection, from $199/mo

Visit Maves →

Maves markets individual prescription treatments and bundles combining GLP-1 therapy, sermorelin and NAD. Its treatment pages describe compounded preparations, online assessment and home delivery. A combined protocol is a different purchase from each medicine separately; its price does not establish the independent cost or evidence for every ingredient.

What Maves prescribes, by goal

Weight

  • SemaglutideFDA-approved
    • Injection (compounded)From $249/mo
  • TirzepatideFDA-approved
    • Injection (compounded)From $349/mo

Semaglutide and tirzepatide pages describe weekly subcutaneous injections. A separate bundle pairs GLP-1 therapy with sermorelin, while a higher bundle adds NAD. An ingredient combination does not establish that muscle preservation or better weight loss has been demonstrated for that particular protocol.

Longevity

  • NAD+Compounding conditions apply
    • Injection (compounded)From $229/mo

NAD is offered by injection with broad energy and healthy-aging claims. The marketing does not establish a clinical outcome study for the preparation. Confirm the prescribed concentration, route and monitoring before relying on a general cellular-energy explanation.

Recovery

  • SermorelinCompounding conditions apply
    • Injection (compounded)From $199/mo

Sermorelin is described as a subcutaneous treatment with recovery, muscle and sleep claims. Ask what outcome is being treated and how response is assessed. A mechanism involving growth hormone does not establish the claimed improvement for every patient.

Sleep

  • SermorelinCompounding conditions apply
    • Injection (compounded)From $199/mo

Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.

Who prescribes

A licensed clinician

The August 2026 telehealth consent identifies the Keeva Medical Group network and affiliated professional entities as responsible for clinical care. Homera Health operates the Maves platform and provides administrative support. The particular Keeva entity depends on the patient’s location. An assigned professional’s credentials can be reviewed, but no individual prescriber is established for every patient.

The current consent allows questionnaires, secure messages and live audio or video encounters. Keeva may request testing or in-person assessment when remote information is insufficient. Clinical decisions remain with the treating professional. Ask how routine reassessment and urgent questions are handled; the program does not replace ongoing local care.

Are labs required?

Not mentioned

The current consent allows clinician-requested testing without establishing a universal included patient laboratory allowance. The older platform agreement describes outside Quest billing and separate diagnostic charges, alongside references to other platforms. Ask which provisions apply to the selected purchase and who pays for required tests. Pharmacy-quality claims do not establish patient bloodwork coverage.

Ready to start with Maves?

Lowest listed price: Sermorelin injection, from $199/mo. Confirm it on the seller’s own site.

What it claims, and what it cites

The homepage uses patient-count and FDA-registered-pharmacy language, alongside protocol benefit claims. Neither establishes FDA approval of a compounded preparation or a controlled outcome study for the bundle. Treatment illustrations also do not identify a pharmacy or verify the contents of a dispensed prescription. Ask for evidence tied to the exact proposed preparation.

How it bills

Current treatment pages separate first-month promotions from ordinary monthly prices. The older January 2022 general agreement describes nonrefundable membership and an approximate 28–30-day renewal cycle. Those older billing provisions need product-specific confirmation; they do not replace the current consent’s clear clinical roles. Obtain the applicable itemized quote and cancellation agreement.

For and against

  • For: Individual products and bundles distinguished
  • For: Administration routes described
  • For: Initial and ordinary prices separated
  • For: Ongoing messaging advertised
  • Against: Individual clinician still needs confirmation
  • Against: Older billing terms need clarification
  • Against: Patient-testing allowance unestablished
  • Against: Bundle-specific clinical benefit unestablished

The evidence behind what it sells

Right for

Someone comparing a named clinical group’s access with the evidence, monitoring and cost of a combined protocol.

Look elsewhere if

Someone assuming an FDA-registered pharmacy claim means the compound or protocol has received FDA approval.

Other sellers for weight

Maves

Frequently asked questions

Does the legal document clearly identify my treating practice?
The August 2026 consent identifies the Keeva network for clinical care and Homera Health for platform support. Confirm the assigned Keeva entity and clinician.
Does a bundle prove the ingredients work better together?
No. A combined offer and its ingredient mechanisms do not establish a clinical outcome study for that particular protocol.

Sources

  • Semaglutide introductory and ordinary program prices
  • Tirzepatide preparation and ordinary price
  • Sermorelin administration and claims
  • NAD injection and program price
  • Membership, testing liability and clinical-entity references
  • Bundle prices and platform claims
  • Current Keeva clinical agreement and platform relationship

See what Maves prescribes today

Maves sets its own prices, plans and the states it serves. Check them before you start.

Written by Leah Garner from Maves’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.